Follow-The-Filings

Holders · period archive

TVRD · Tvardi Therapeutics Inc.

Q4 2025 13F holders among managers we track latest ownership dossier

Ticker
TVRD
Type
Equity
Class
COM
Total reported value ($000, long equity)
Manager Report date Value Shares